Suchergebnisse - "Spinner, Christoph D"

PubPharm (12)

1

AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999-2018

enthalten in: Infection | 2024

von Pantke, A. | Kollan, C. | Gunsenheimer-Bartmeyer, B. | +108

2

Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir : a DUALIS sub-study

enthalten in: AIDS care | 2022

von Olliges, E. | Bührlen, B. | Fischer, F. | +14

3

Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes

enthalten in: HIV research & clinical practice | 2021

von Monin, M. | Kümmerle, T. | Schneider, J. | +16

4

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +9

5

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis : week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The lancet. HIV | 2021

von Ogbuagu, O. | Ruane, P. | Podzamczer, D. | +118

ErratumIn: Lancet HIV. 2021 Dec;8(12):e734. - PMID 34571044

6

Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1

enthalten in: HIV research & clinical practice | 2020

von Huhn, G. | Wilkin, A. | Mussini, C. | +8

7

Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-20181

enthalten in: Emerging infectious diseases | 2020

von Stecher, M. | Chaillon, A. | Stephan, C. | +13

8

Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir : a pharmacokinetic subgroup analysis of the DUALIS study

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Weidlich, S. | Boesecke, C. | Schneider, J. | +36

9

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1 : subgroup analyses of the phase 3 AMBER study

enthalten in: HIV research & clinical practice | 2019

von Rashbaum, B. | Spinner, C. | McDonald, C. | +6

10

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2019

von van de Vijver, D. | Richter, A. | Boucher, C. | +7